Development of Mitochondria Targeting AIE‐Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents
Advanced Healthcare Materials · 2023-04 · 12 (9)
DOI: 10.1002/adhm.202202411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.12.2022. Verfasst von Geeta Kumari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India. Hauptthemen laut MEDLINE: Iridium, Malaria, Falciparum, Mitochondria, Plasmodium falciparum. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
The emergence of resistance to conventional antimalarial treatments remains a major cause for concern. New drugs that target the distinct development stages of Plasmodium parasites are required to address this risk. Herein, water‐soluble aggregation‐induced emission active cyclometalated iridium(III) polypyridyl complexes ( Ir1–Ir12 ) are developed for the elimination of malaria parasites. Remarkably, these complexes show potent antimalarial activity in low nanomolar range against 3D7 (chloroquine and artemisinin sensitive strain), RKL9 (chloroquine resistant strain), and R539T (artemisinin resistant strains) strains of Plasmodium falciparum with faster killing rate of malaria parasites. Concomitantly, these complexes exhibit efficient in vivo antimalarial activity against both the asexual and gametocyte stages of Plasmodium berghei malaria parasite, suggesting promising transmission‐blocking potential. The complexes tend to localize into mitochondria of P. falciparum determined by image and cell‐based assay. The mechanistic studies reveal that these complexes exert their antimalarial activity by increasing reactive oxygen species levels and disrupting its mitochondrial membrane potential. Furthermore, the mitochondrial‐dependent antimalarial activity of these complexes is confirmed in yeast model. Thus, this study for the first time highlights the potential role of targeting P. falciparum mitochondria by iridium complexes in discovering and developing the next‐generation antimalarial agents for treating multidrug resistant malaria parasites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
- School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
- Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Gautam Budhha Nagar, Uttar Pradesh, 201314, India.
ORCID-Profile: Pijus K Sasmal
Zitieren
APA
Kumari, G., Gupta, A., Sah, R. K., Gautam, A., Saini, M., Gupta, A., Kushawaha, A. K., Singh, S., & Sasmal, P. K. (2023). Development of Mitochondria Targeting AIE‐Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents. Advanced Healthcare Materials, 12(9). https://doi.org/10.1002/adhm.202202411
Vancouver
Kumari G, Gupta A, Sah RK, Gautam A, Saini M, Gupta A, et al. Development of Mitochondria Targeting AIE‐Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents. Advanced Healthcare Materials. 2023;12(9). doi:10.1002/adhm.202202411
BibTeX
@article{Kumari2023,
author = {Kumari, Geeta and Gupta, Ajay and Sah, Raj Kumar and Gautam, Aryan and Saini, Monika and Gupta, Aashima and Kushawaha, Akhilesh K and Singh, Shailja and Sasmal, Pijus K},
title = {Development of Mitochondria Targeting AIE‐Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {9},
doi = {10.1002/adhm.202202411}
}
EUVIMED